ストックスクリーナーアプリを入手
0.8926
1.43%
0.0126
アフターアワーズ：
.89
-0.0026
-0.29%
Kronos Bio Inc (KRON) 最新ニュース
Two Sigma Investments LP Cuts Stock Holdings in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World
Kronos Bio to Exit Cambridge Lab, Returning Prime Space to Market Amid Biotech Downturn, Reports BBJ - Boston Real Estate Times
Squarepoint Ops LLC Makes New $93,000 Investment in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World
Kronos Bio sends Cambridge lab space back to market - The Business Journals
Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives - mx.advfn.com
kronos bio ends lease early, expects cost savings - Investing.com
Kronos Bio Terminates Cambridge Lease Agreement - TipRanks
Kronos Bio IncTerminates Office Lease At 301 Binney StreetSEC Filing - marketscreener.com
Millennium Management LLC Has $1.63 Million Holdings in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World
Shareholders Filed a Lawsuit Against Kronos Bio for Merger Disclosure Failures - TradingView
Kronos Bio ($KRON) Misleading Merger Proxy and Insider Enrichment Case - TradingView
Kronos Bio Shareholder Says Sale Unfairly Benefits Execs - Law360
Kronos Bio, Board Sued by Shareholder Over Concentra Buyout Deal - Bloomberg Law News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AXL, KRON, PRA, SWTX on Behalf of Shareholders - GlobeNewswire Inc.
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (NasdaqKRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (NasdaqXAGE), Southern States Bancshare - TradingView
Kronos Bio discovers p300 inhibitors - BioWorld MedTech
Weekly CEO Buys Highlight - GuruFocus
Concentra Biosciences Agrees to Acquire Kronos Bio - Contract Pharma
KRONOS BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kronos Bio, Inc.KRON - Business Wire
KRON Shares Experience Decline in Value - knoxdaily.com
why Kronos Bio Inc [KRON] is a Good Choice for Investors After New Price Target of $1.00 - dbtnews.com
Kronos shares slump on Concentra takeover news - The Pharma Letter
Kronos Bio (KRON) to Merge with Concentra Biosciences in $0.57 P - GuruFocus
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kronos Bio, Inc.KRON - PR Newswire
Struggling Peninsula biotech with Gilead lineage is latest purchase for activist investorSan Francisco Business Times - The Business Journals
Now Is The Time To Build A Position In Kronos Bio Inc (NASDAQ:KRON) - Marketing Sentinel
KRON’s Stock Market Labyrinth: Navigating 2023’s Gains and Declines - investchronicle.com
Kronos Bio Enters Deal to be Acquired by Concentra Biosciences; Shares Fall - marketscreener.com
Today’s watch list includes Kronos Bio Inc (NASDAQ:KRON) stock - uspostnews.com
Kronos Bio stock hits 52-week low at $0.68 amid market challenges - Investing.com India
After hunt for alternatives, Kronos Bio selects Tang Capital’s Concentra for a deal - Endpoints News
Kronos Bio (KRON) to be Acquired by Concentra Biosciences in Strategic Merger | KRON Stock News - GuruFocus
Shareholder Alert: The Ademi Firm Investigates Whether Kronos Bio, Inc. is Obtaining a Fair Price for Its Public Shareholders - The Joplin Globe
KRON Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kronos Bio, Inc. Is Fair to Shareholders - The Joplin Globe
Concentra To Acquire Kronos Bio - Nasdaq
Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right - The Manila Times
Kronos Bio agrees to Concentra Biosciences acquisition - Investing.com
Kronos Bio Enters into Agreement to Be Acquired by - GlobeNewswire
Kronos Bio (KRON) Projected to Announce Quarterly Earnings on Thursday - Defense World
Renaissance Technologies LLC Has $1.11 Million Position in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World
Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com Australia
Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com Canada
Kronos Bio Announces Lease Termination Agreement - TipRanks
Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times
Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
Kronos Bio Reports 2024 Financial Results - TipRanks
Non-Hodgkin’s Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail
1.91%
1.17%
大文字化:
|
ボリューム (24 時間):